Clinical trial
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting…
NCT00294008 · Janssen Korea, Ltd., Korea, Industry · Completed
Key facts
| NCT number | NCT00294008 |
|---|---|
| Title | A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) |
| Official title | Electronic Schizophrenia Treatment Adherence Registry(e-STAR): An Observational, International Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres |
| Lead sponsor | Janssen Korea, Ltd., Korea, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Schizophrenia, Tranquilizing Agents, Mental Disorders, Therapeutic Uses, Physiological Effects of Drugs, Psychotropic Drugs, Antipsychotic Agents |
| Intervention type | Drug |
| Interventions | Risperdal Consta |
| Enrollment | 230 |
| Start date | Dec 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Feb 20, 2006 |
| Last update posted | Apr 3, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: